ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Tolero Pharmaceuticals and AbbVie partner to develop AML therapy
pharmaceutical
August 22, 2018Biopharmaceutical firm Tolero Pharmaceuticals and AbbVie have formed a clinical research alliance to evaluate venetoclax and alvocidib combination for relapsed or refractory acute myeloid leukaemia (AML) treatment. -
Astellas files experimental AML therapy
pharmatimes
April 27, 2018Astellas has filed its experimental Acute Myeloid Leukaemia (AML) therapy gilteritinib with US regulators, seeking approval for its use to treat FLT3 mutation-positive (FLT3mut+) relapsed or refractory forms of the blood cancer.
Pharma Sources Insight January 2025
